Vir Biotechnology Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -146.8% | – | – | |
| – | +538.0% | +63.9% | +20.5% | +6.8% | +16.7% | +186.8% | -25.2% | +45.3% | |
| – | +5.7% | +72.6% | +216.6% | +203.6% | +21.8% | +9.0% | -29.5% | -37.5% | |
| – | – | +394.5% | +39.8% | +2.7% | +924.1% | – | – | – | |
| – | +157.0% | -34.3% | +259.8% | -2,228.6% | – | -145.8% | – | – | |
| – | +198.8% | +9.1% | -26.7% | +233.1% | +211.7% | -68.3% | -66.2% | -33.8% | |
| – | +101.5% | +323.8% | -96.2% | +1,327.8% | +747.5% | – | +203.1% | -37.8% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | -100.0% | – | -95.3% | -79.0% | – | – | – | |
| – | +0.0% | +0.0% | -122.6% | +3.6% | +0.4% | +10.4% | – | – | |
| – | -90.8% | +1,698.6% | +17.9% | -81.1% | -65.4% | -78.8% | -40.5% | -13.7% | |
| – | -174.1% | – | +418.0% | -126.8% | – | -220.2% | – | -235.2% | |
| – | – | – | – | – | – | -150.2% | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.